Overview

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Status:
Completed
Trial end date:
2020-05-12
Target enrollment:
Participant gender:
Summary
This is a study comparing the defibrotide prophylaxis arm vs standard of care arm for the prevention of aGvHD.
Phase:
Phase 2
Details
Lead Sponsor:
Jazz Pharmaceuticals
Treatments:
Defibrotide